Abstract
Already in the 19th century, it was accepted that tissues display clot-promoting activity. The awareness that a single protein was accountable for this pro-coagulant effect led to the detection of tissue factor (tissue factor), but for many years it was thought that tissue factor activity was restricted to the activation of an auxiliary pathway that had little biological significance. Today tissue factor is recognised to be the primary biological initiator of the coagulation cascade. In silico studies have highlighted the high degree of structural similarity of tissue factor with the super family of interferon receptors. The cytokine class II receptor family has probably evolved from an ancient gene coding for a pre-eukaryotic extracellular protein. Tissue factor evolved from this protein and matching sequences are found in invertebrates, especially insects. From tissue factor, the other receptors evolved. Strikingly, the common evolutionary origin of tissue factor and cytokine receptors is reflected in identical signalling. The evolutionary origin of tissue factor is the subject of the present review.
Keywords: Chordates, cytokines receptors, tissue factor, prokariotic secretion system 2
Current Genomics
Title: Functional Evolution of Tissue Factor, the Archetype of the Cytokine Receptor Family
Volume: 6 Issue: 6
Author(s): C. A. Spek, M. V. Zoelen, S. H. Diks and M. P. Peppelenbosch
Affiliation:
Keywords: Chordates, cytokines receptors, tissue factor, prokariotic secretion system 2
Abstract: Already in the 19th century, it was accepted that tissues display clot-promoting activity. The awareness that a single protein was accountable for this pro-coagulant effect led to the detection of tissue factor (tissue factor), but for many years it was thought that tissue factor activity was restricted to the activation of an auxiliary pathway that had little biological significance. Today tissue factor is recognised to be the primary biological initiator of the coagulation cascade. In silico studies have highlighted the high degree of structural similarity of tissue factor with the super family of interferon receptors. The cytokine class II receptor family has probably evolved from an ancient gene coding for a pre-eukaryotic extracellular protein. Tissue factor evolved from this protein and matching sequences are found in invertebrates, especially insects. From tissue factor, the other receptors evolved. Strikingly, the common evolutionary origin of tissue factor and cytokine receptors is reflected in identical signalling. The evolutionary origin of tissue factor is the subject of the present review.
Export Options
About this article
Cite this article as:
Spek A. C., Zoelen V. M., Diks H. S. and Peppelenbosch P. M., Functional Evolution of Tissue Factor, the Archetype of the Cytokine Receptor Family, Current Genomics 2005; 6 (6) . https://dx.doi.org/10.2174/138920205774483025
DOI https://dx.doi.org/10.2174/138920205774483025 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Neuronal Expression of Junctional Adhesion Molecule-C is Essential for Retinal Thickness and Photoreceptor Survival
Current Molecular Medicine Melatonin in the Biliary Tract and Liver: Health Implications
Current Pharmaceutical Design Overcoming the Drug Resistance Problem with Second-Generation Tyrosine Kinase Inhibitors: From Enzymology to Structural Models
Current Medicinal Chemistry The Osteopontin Tissue Level as a Breast Cancer Biomarker in Females After Mastectomy Measured by the Capillary Gel Electrophoresis Technique
Combinatorial Chemistry & High Throughput Screening Tumor Vasculature Targeting Through NGR Peptide-Based Drug Delivery Systems
Current Pharmaceutical Biotechnology Quality of Life in Patients with β-thalassemia Major: Short-term and Long-term Effects After Haematopoietic Stem Cell Transplantation
Current Stem Cell Research & Therapy New Molecular Targets of Anticancer Therapy – Current Status and Perspectives
Current Medicinal Chemistry Unexpected High Levels of Vorinostat when Combined with Vinorelbine in Patients with Advanced Cancer
Current Clinical Pharmacology Approaches to Gastrointestinal Cytoprotection: From Isolated Cells, Via Animal Experiments to Healthy Human Subjects and Patients with Different Gastrointestinal Disorders
Current Pharmaceutical Design Therapeutic Drugs in Bone Loss-Associated Disorders: Clinical Outcomes and Challenges
Current Drug Targets The Role of Essential Oils and the Biological Detoxification in the Prevention of Aflatoxin Borne Diseases
Current Topics in Medicinal Chemistry Alzheimer’s Disease – Future Therapy Based on Dendrimers
Current Neuropharmacology Pharmacological Management of Psychosis in Parkinson Disease: A Review
Current Drug Therapy Chitosan: A Versatile Biomedical Polymer
Recent Patents on Biomedical Engineering (Discontinued) Pharmacokinetics of CNT-based Drug Delivery Systems
Current Drug Metabolism The Use of Statins in Hematopoietic Stem Cell Transplantation
Current Stem Cell Research & Therapy Regulation of Ocular Immune Responses by Corneal Epithelium
Current Immunology Reviews (Discontinued) Glucagon-Like Peptide-1-Mediated Modulation of Inflammatory Pathways in the Diabetic Brain: Relevance to Alzheimer’s Disease
Current Alzheimer Research Signal Transduction Pathways and Transcription Factors as Therapeutic Targets in Inflammatory Disease: Towards Innovative Antirheumatic Therapy
Current Pharmaceutical Design An Overview of Recent Patents on Nanosuspension
Recent Patents on Drug Delivery & Formulation